GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

There's growing evidence to suggest that GLP-1 drugs, which include Ozempic's semaglutide, may be useful for treating alcohol ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Rybelsus is an oral tablet best taken on an empty stomach. Avoiding certain types of food in your diet may help manage blood sugar levels and minimize certain side effects of the drug. Limiting ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Common benefits include: There are several GLP-1 agonist medications on the market. Most GLP-1 agonists are available as injections. Today, only Rybelsus is available as an oral pill. Talk to ...

People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why - There’s no direct link ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

They include Trelegy Ellipta (asthma, COPD) and three big-name drugs for weight loss, diabetes and heart disease: Rybelsus, ...